Restatement (Details) - USD ($) | Sep. 30, 2022 | Jun. 30, 2022 | Sep. 30, 2021 | Jun. 30, 2021 |
Cash | $ 222 | $ 392 | $ 10,586 | |
Total current assets | 222 | 392 | | |
Total assets | 222 | 392 | | |
Accounts payable and accrued liabilities | (1,146) | (4,903) | | |
Accounts payable and accrued liabilities | 1,146 | 4,903 | | |
Due to related party (Note 3) | 65,581 | 61,581 | | |
Total current liabilities | (66,727) | (66,484) | | |
Loans Payable (Note 5) | 16,000 | 16,000 | | |
Total liabilities | (82,727) | (82,484) | | |
Common stock authorized: 10,000,000,000 common shares, $0.0001 par value 63,750,000 shares issued and outstanding as of September 30, 2022 and June 30, 2022 | 6,375 | 6,375 | | |
Additional paid-in capital | 28,675 | 28,675 | | |
Accumulated deficit | (117,555) | (117,142) | | |
Total stockholders' deficit | (82,505) | (82,092) | $ (46,479) | $ (32,649) |
Total liabilities and stockholders' deficit | 222 | $ 392 | | |
As Previously Reported [Member] | | | | |
Cash | 222 | | | |
Total current assets | 222 | | | |
Total assets | 222 | | | |
Accounts payable and accrued liabilities | (4,146) | | | |
Accounts payable and accrued liabilities | 4,146 | | | |
Due to related party (Note 3) | 65,581 | | | |
Total current liabilities | (69,727) | | | |
Loans Payable (Note 5) | 16,000 | | | |
Total liabilities | (85,727) | | | |
Common stock authorized: 10,000,000,000 common shares, $0.0001 par value 63,750,000 shares issued and outstanding as of September 30, 2022 and June 30, 2022 | 6,375 | | | |
Additional paid-in capital | 28,675 | | | |
Accumulated deficit | (120,555) | | | |
Total stockholders' deficit | (85,505) | | | |
Total liabilities and stockholders' deficit | 222 | | | |
Restatement Adjustments (Member) | | | | |
Cash | 0 | | | |
Total current assets | 0 | | | |
Total assets | 0 | | | |
Accounts payable and accrued liabilities | (3,000) | | | |
Accounts payable and accrued liabilities | 3,000 | | | |
Due to related party (Note 3) | 0 | | | |
Total current liabilities | (3,000) | | | |
Loans Payable (Note 5) | 0 | | | |
Total liabilities | (3,000) | | | |
Common stock authorized: 10,000,000,000 common shares, $0.0001 par value 63,750,000 shares issued and outstanding as of September 30, 2022 and June 30, 2022 | 0 | | | |
Additional paid-in capital | 0 | | | |
Accumulated deficit | 3,000 | | | |
Total stockholders' deficit | 3,000 | | | |
Total liabilities and stockholders' deficit | 0 | | | |
As Restated [Member] | | | | |
Cash | 222 | | | |
Total current assets | 222 | | | |
Total assets | 222 | | | |
Accounts payable and accrued liabilities | (1,146) | | | |
Accounts payable and accrued liabilities | 1,146 | | | |
Due to related party (Note 3) | 65,581 | | | |
Total current liabilities | (66,727) | | | |
Loans Payable (Note 5) | 16,000 | | | |
Total liabilities | (82,727) | | | |
Common stock authorized: 10,000,000,000 common shares, $0.0001 par value 63,750,000 shares issued and outstanding as of September 30, 2022 and June 30, 2022 | 6,375 | | | |
Additional paid-in capital | 28,675 | | | |
Accumulated deficit | (117,555) | | | |
Total stockholders' deficit | (82,505) | | | |
Total liabilities and stockholders' deficit | $ 222 | | | |